Resources

Type of publications
Regions
Diseases
4864 results found
2017 ∙ Sisson, Helen Gardiner, Eric Watson, Roger
Vaccination timeliness in preterm infants: an integrative review of the literature
Newborn Coverage Ethical issues
Rating:
Not applicable
2017 ∙ Wang, B. Shao, X. Wang, D. Xu, D. Zhang, J. A.
Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis
All age groups Safety
Rating:
Critically low
2017 ∙ Mipatrini, D. Stefanelli, P. Severoni, S. Rezza, G.
Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence
Europe All age groups Hepatitis B Measles Rubella Mumps Tetanus Poliomyelitis Pertussis Diphtheria Varicella Meningococcal disease Coverage
Rating:
Not applicable
2017 ∙ Eriksson, P. Gessner, B. D. Jaillard, P. Morgan, C. Gargasson, J. B. le
Vaccine vial monitor availability and use in low- and middle-income countries: a systematic review. (Special Issue: Building next generation immunization supply chains.)
All age groups Healthcare workers Low and Middle Income Countries Acceptance
Rating:
Not applicable
2017 ∙ Mailand, M. T. Frederiksen, J. L.
Vaccines and multiple sclerosis: a systematic review
All age groups Hepatitis B Human papillomavirus (HPV) Influenza Measles Mumps Rubella Smallpox Tetanus Poliomyelitis Diphtheria Tuberculosis Safety
Rating:
Critically low
2017 ∙ Loze, P. M. Nasciben, L. B. Sartori, A. M. C. Itria, A. Novaes, H. M. D. de Soarez, P. C.
Vaccines are different: A systematic review of budget impact analyses of vaccines
All age groups Economic aspects
Rating:
Not applicable
2017 ∙ Simancas-Racines, Daniel Franco Juan, V. A. Guerra Claudia, V. Felix Maria, L. Hidalgo, Ricardo Martinez-Zapata Maria, José
Vaccines for the common cold
All age groups Efficacy/effectiveness Safety
Rating:
High
2017 ∙ Pasquini-Descomps, H. Brender, N. Maradan, D.
Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions
All age groups Influenza Economic aspects
Rating:
Not applicable
2017 ∙ SAGE
Grade Tables - PCV
Evidence to recommendation table Pneumococcal disease
Download:
2017 ∙ SAGE
SAGE evidence to recommendations table: Pneumococcal Conjugate Vaccine (PCV)
Evidence to recommendation table Pneumococcal disease
Download:
Loading...